Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4)
Protein arginine deiminase type IV (PAD4) is responsible for the posttranslational conversion of peptidylarginine to peptidylcitrulline. Citrullinated protein is the autoantigen in rheumatoid arthritis, and therefore, PAD4 is currently a promising therapeutic target for the disease. Recently, we rep...
Saved in:
Main Authors: | Teo, Chian Ying, Tejo, Bimo Ario, Leow, Adam Thean Chor, Salleh, Abu Bakar, Abdul Rahman, Mohd Basyaruddin |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley & Sons A/S
2017
|
Online Access: | http://psasir.upm.edu.my/id/eprint/59664/1/Novel%20furan-containing%20peptide-based%20inhibitors%20of%20protein%20arginine%20deiminase%20type%20IV%20%28PAD4%29.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-silico identification of potential Protein Arginine Deiminase IV (PAD4) inhibitors
by: Ibrahim, Zalikha, et al.
Published: (2016) -
Ligand-based virtual screening for the discovery of inhibitors for protein arginine deiminase type 4 (PAD4)
by: Teo, Chian Ying, et al.
Published: (2013) -
Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides
by: Ahmad Nadzirin, Izzuddin, et al.
Published: (2021) -
Screening, design, synthesis and bioactivity of inhibitors against protein arginine deiminase type IV /
by: Teo, Chian Ying.
Published: (2015) -
Screening, design, synthesis and bioactivity of inhibitors against Protein Arginine Deiminase type IV
by: Teo, Chian Ying
Published: (2015)